Tirzepatide has emerged as a groundbreaking treatment for type 2 diabetes, offering promising results. However, the price of this innovative drug and its availability have become key issues for patients and healthcare professionals. While tirzepatide has been approved by regulatory agencies, its high-priced nature presents a significant obstacle t